A5110385775- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Cardiac, Anesthesia and Surgical Outcomes
- Esophageal and GI Pathology
- Myasthenia Gravis and Thymoma
- Head and Neck Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal and Anal Carcinomas
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- Aortic aneurysm repair treatments
- Innovations in Medical Education
- Meningioma and schwannoma management
- Salivary Gland Tumors Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- Gallbladder and Bile Duct Disorders
- Aortic Disease and Treatment Approaches
- Diversity and Career in Medicine
- Cancer Genomics and Diagnostics
- Global Health Workforce Issues
- Pancreatitis Pathology and Treatment
- COVID-19 and healthcare impacts
- Management of metastatic bone disease
- Colorectal Cancer Screening and Detection
University of Minnesota
2022-2024
The University of Texas Southwestern Medical Center
2024
Twitter (United States)
2024
University of Minnesota Medical Center
2023
Einstein Healthcare Network
2017-2020
University of Miami
2018
Einstein Medical Center Philadelphia
2017-2018
Temple University Hospital
2018
Mayo Clinic in Arizona
2016
Center for Innovation
2014-2015
Transarterial chemoembolization (TACE) is the most common treatment for patients with unresectable hepatocellular carcinoma (HCC). Post-embolization syndrome (PES) a post-TACE complication. The goal of this study was to evaluate PES as an early predictor long-term outcome.A retrospective cohort HCC treated TACE at tertiary referral centre performed (2008-2014). Patients were categorized on basis PES, defined fever or without abdominal pain within 14 days TACE. primary outcome overall...
A VTB program positively affected the process of care for patients with HCC by improving quality and timeliness multidisciplinary evaluation process.
Malignant neoplasms of the hepatopancreaticobiliary (HPB) system constitute a significant public health problem worldwide. Treatment coordination for these tumors is challenging and can result in substandard care. Referral centers HPB disease have been used as strategy to improve postoperative outcomes, but their effect on accomplishing regionalization care improving quality cancer not well known.To evaluate implementing multidisciplinary surgical program (HPB-SP) care, outcomes within an...
Objective Although rare, thymic neuroendocrine tumors (TNET) and carcinoma (TC) are the most common nonthymomatous malignancies; their survival outcomes have not been thoroughly compared. We analyzed clinical, treatment, characteristics of TNET TC. Methods retrospectively identified patients with a histologic diagnosis or TC in National Cancer Database (2004 to 2015). Exclusion criteria were age <18 years unstaged tumors. Descriptive statistics, analysis, multivariable Cox regression...
The optimal treatment of esophageal cancer in octogenarians is controversial. While the safety esophagectomy has been demonstrated elderly patients, surgery and multimodality therapy are still offered to a select group. Additionally, long-term outcomes have not thoroughly compared those younger patients. We sought compare between non-octogenarians National Cancer Database (2004-2014). major endpoints were early postoperative mortality survival. A total 107,921 patients identified...
Subxiphoid-subcostal thoracoscopic thymectomy (ST) is an emerging alternative to transthoracic thymectomy. Potential advantages of ST are the avoidance intercostal incisions and visualization both phrenic nerves in their entirety. We describe our experience with compare results previous thymectomy.We conducted institutional review board-exempt retrospective all patients who had a minimally invasive from August 2008 October 2021. excluded sternotomy or radiological evidence invasion into...
Abstract Aim The optimal treatment approach for adenocarcinoma of the rectosigmoid junction remains unclear. aim this work was to compare outcomes neoadjuvant chemoradiation (NCR) and adjuvant chemotherapy (AC) cancer junction. Method This a nationwide, retrospective cohort study (2004–2015) using hospital‐based data (National Cancer Database). All patients who underwent resection with curative intent locally advanced [American Joint Committee on (AJCC) Stages II III] were included....
Background: Several studies have shown racial disparities in lung cancer care the United States Black and Hispanic populations but not many included American Indian/Alaska Native (AI/AN) patients. We retrospectively evaluated factors associated with receipt of guideline-concordant AI/AN non-Hispanic White (NHW) patients stage I non-small cell (NSCLC) describe relationship between survival outcomes these populations. Methods: Using National Cancer Database, we identified NHW diagnosed NSCLC...
Sex, racial, and ethnic disparities in the incidence prevalence of Barrett’s esophagus esophageal adenocarcinoma are well studied. Despite advances surveillance techniques multimodality treatment, exist outcomes with not all populations benefiting proportionately. A deeper understanding cause nature these could help guide meaningful action toward mitigating differences. This review focuses on sex, racial differences incidence, adenocarcinoma, delves into literature potential causes for...
To report our updated experience in the management of esophageal perforation resulting from anterior cervical spine surgery, and to compare two wound approaches.
Healthcare disparities significantly affect access to care and outcomes in lung cancer patients. The Patient Protection Affordable Care Act (ACA) Medicaid expansion (ME) was enacted with the aim of improving quality affordable healthcare. This study aims determine impact ME on for patients cancer.